| Brain Glioblastoma studied in …STUDIED_INderived61 of 61show fewer |
|---|
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613841early Phase 1 · recruiting Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911388Phase 1 · recruiting HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Cerebellar Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03657576Phase 1 · completed Trial of C134 in Patients With Recurrent GBM · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180927Phase 1/Phase 2 · not yet recruiting DLL3 CAR-T Therapy Targeting Brain Tumors · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Cerebellar Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170141Phase 1 · terminated Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991101Phase 2 · recruiting Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464925Phase 1 · recruiting A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177964Phase 2 · recruiting Lerapolturev (PVSRIPO) in GBM · condition mapped CURATED_BROADER · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05627323Phase 1 · terminated CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02649582Phase 1/Phase 2 · active not recruiting Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222309Phase 1 · suspended Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979064NA · recruiting Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116137NA · enrolling by invitation The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04105374Phase 2/Phase 3 · withdrawn Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04968366Phase 1 · completed Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076513early Phase 1 · active not recruiting Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06815432Phase 1 · recruiting GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04825275early Phase 1 · terminated Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06193174Phase 1 · terminated Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04869449early Phase 1 · terminated Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179328Phase 1 · recruiting Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03958240NA · recruiting Deciphering Mechanisms Underlying Cancer Immunogenicity · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Stem Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04388475Phase 2 · completed Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05685004Phase 2/Phase 3 · active not recruiting Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04479241Phase 2 · completed LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03047473Phase 2 · completed Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03665545Phase 1/Phase 2 · completed Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01430351Phase 1 · terminated Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05801159completed [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06845020not yet recruiting CSF Proteomic Characterization of Glioblastomas · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02078648Phase 1/Phase 2 · completed Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03154190NA · completed Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04842513Phase 1 · completed Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03732352Phase 2 · completed 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06283927recruiting The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06273176recruiting The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186440Phase 1/Phase 2 · unknown Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146725recruiting The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03861299NA · recruiting The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02137759Phase 2 · unknown MRSI to Predict Response to RT/TMZ ± Belinostat in GBM · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05363826Phase 1 · unknown Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac® · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311920Phase 1 · completed Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095441Phase 1 · unknown A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02302235Phase 2 · completed Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02885272early Phase 1 · completed FDG PET Imaging in Diagnosing Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04854044Phase 1 · withdrawn ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04674579unknown Automatic Segmentation MRI Cerebral Glioma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Cerebral Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03997136unknown Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas. · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884741Phase 3 · completed Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337426Phase 1 · completed Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02395692Phase 2 · terminated Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03633552Phase 3 · unknown Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003456Phase 2 · completed Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003474Phase 2 · completed Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02348255Phase 2 · withdrawn NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660543NA · completed MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521090Phase 1/Phase 2 · withdrawn EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma · condition mapped ONTOLOGY_EXACT · 61 trials mapped (22 active) | — | — | Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02474966Phase 2 · completed Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study · condition mapped ALIAS · 61 trials mapped (22 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |